全文获取类型
收费全文 | 3305篇 |
免费 | 281篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 122篇 |
妇产科学 | 131篇 |
基础医学 | 327篇 |
口腔科学 | 115篇 |
临床医学 | 460篇 |
内科学 | 741篇 |
皮肤病学 | 43篇 |
神经病学 | 168篇 |
特种医学 | 248篇 |
外科学 | 575篇 |
综合类 | 77篇 |
一般理论 | 22篇 |
预防医学 | 239篇 |
眼科学 | 12篇 |
药学 | 99篇 |
中国医学 | 5篇 |
肿瘤学 | 184篇 |
出版年
2022年 | 16篇 |
2021年 | 38篇 |
2020年 | 28篇 |
2019年 | 50篇 |
2018年 | 84篇 |
2017年 | 69篇 |
2016年 | 77篇 |
2015年 | 70篇 |
2014年 | 90篇 |
2013年 | 123篇 |
2012年 | 153篇 |
2011年 | 152篇 |
2010年 | 135篇 |
2009年 | 118篇 |
2008年 | 140篇 |
2007年 | 135篇 |
2006年 | 139篇 |
2005年 | 137篇 |
2004年 | 128篇 |
2003年 | 104篇 |
2002年 | 108篇 |
2001年 | 82篇 |
2000年 | 69篇 |
1999年 | 70篇 |
1998年 | 85篇 |
1997年 | 77篇 |
1996年 | 71篇 |
1995年 | 76篇 |
1994年 | 39篇 |
1993年 | 53篇 |
1992年 | 49篇 |
1991年 | 67篇 |
1990年 | 70篇 |
1989年 | 62篇 |
1988年 | 59篇 |
1987年 | 61篇 |
1986年 | 64篇 |
1985年 | 47篇 |
1984年 | 39篇 |
1983年 | 39篇 |
1981年 | 33篇 |
1980年 | 23篇 |
1979年 | 30篇 |
1978年 | 23篇 |
1977年 | 25篇 |
1976年 | 24篇 |
1975年 | 22篇 |
1974年 | 19篇 |
1973年 | 23篇 |
1972年 | 18篇 |
排序方式: 共有3598条查询结果,搜索用时 0 毫秒
1.
2.
Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand
PA Crock JD McKenzie AM Nicoll NJ Howard W Cutfield LK Shield G Byrne 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(4):381-386
Benign intracranial hypertension (BIH) is reported in three children from Australia and one from New Zealand, who were being treated with recombinant human growth hormone (rhGH). Three males and one female, aged between 10.5 and 14.2 y, developed intracranial hypertension within 2 weeks to 3 months of starting treatment. A national database, OZGROW, has been prospectively collecting data on all 3332 children treated with rhGH in Australia and New Zealand from January 1986 to 1996. The incidence of BIH in children treated with growth hormone (GH) is small, 1.2 per 1000 cases overall, but appears to be greater with biochemical GHD (<10IUml -1 ), i.e. 6.5/1000 (3 in 465 cases), relative risk 18.4, 95% confidence interval 1.9-176.1, than in all other children on the database. The incidence in patients with Turner's syndrome was 2.3/1000 (1 in 428 cases). No cases in patients with partial GHD (10–20 IUml -1 ) or chronic renal failure were identified. Possible causative mechanisms are discussed. The authors'practice is now to start GH replacement at less than the usual recommended dose of 14IUm-2 week-1 in those children considered to be at high risk of developing BIH. Ophthalmological evaluation is recommended for children before and during the first few months following commencement of rhGH therapy and is mandatory in the event of peripheral or facial oedema, persistent headaches, vomiting or visual symptoms. The absence of papilledema does not exclude the diagnosis. 相似文献
3.
4.
D L Cohen L B McCullough R W Kessel A Y Apostolides E R Alden K J Heiderich 《Journal of medical education》1987,62(10):789-798
When medical students become involved in patient care, concerns are raised that have ethical and possibly legal implications. In order to determine compliance with the guidelines of the U.S. government and the Joint Committee on Accreditation of Hospitals pertaining to informed consent, the authors conducted a study of hospital administrators, medical school department chairpersons, and medical school deans (with response rates ranging from 82.3 to 95.1 percent) concerning policies on student involvement in patient care. The results show that only 37.5 percent of all responding teaching hospitals specifically informed patients that students would be involved in care. Only 51 percent of the responding medical schools that specifically gave their students instruction or guidance on initial patient interaction as a matter of policy insisted that their students introduce themselves as students and clarify their role in patient care. The authors conclude that medical educators' compliance with the ethical requirements of informed consent is incomplete. 相似文献
5.
6.
7.
8.
9.
Platelet utilization in a university hospital 总被引:3,自引:0,他引:3
Two hundred forty-three patients received 22,717 U of platelets in our hospital during a three-month period. Those with hematologic diseases accounted for 43% of the patients but used 86% of the platelets. Sixty-eight percent of the transfusions were given to prevent bleeding and 32% were given to treat active bleeding. Ninety-two percent of therapeutic transfusions but only 22% of prophylactic transfusions met guidelines established by the Transfusion Therapeutics Committee of the University of Minnesota Hospital and Clinics, Minneapolis. However, 78% of prophylactic platelet transfusions that did not meet the guidelines involved patients with at least one clinical factor that their physicians believed placed them at an increased risk of bleeding. Following this analysis, the guidelines were modified and applied prospectively to requests for platelets. This resulted in a 14% decrease in the number of platelet units used during the following year. We conclude that published recommendations for platelet transfusions do not reflect the complex nature of many patients' conditions and that the use of guidelines developed by the medical staff can alter the use of platelet transfusions. 相似文献
10.